ETF Managers Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-21,560
| Closed | -$367K | – | 755 |
|
|
2021
Q3 | $367K | Sell |
21,560
-1,484
| -6% | -$25.3K | 0.01% | 578 |
|
|
2021
Q2 | $367K | Sell |
23,044
-16,648
| -42% | -$265K | 0.01% | 572 |
|
|
2021
Q1 | $735K | Buy |
39,692
+7,089
| +22% | +$131K | 0.01% | 323 |
|
|
2020
Q4 | $590K | Buy |
32,603
+3,919
| +14% | +$70.9K | 0.01% | 306 |
|
|
2020
Q3 | $554K | Buy |
28,684
+2,230
| +8% | +$43.1K | 0.02% | 289 |
|
|
2020
Q2 | $673K | Buy |
26,454
+2,864
| +12% | +$72.9K | 0.02% | 233 |
|
|
2020
Q1 | $428K | Buy |
23,590
+2,096
| +10% | +$38K | 0.02% | 230 |
|
|
2019
Q4 | $731K | Buy |
21,494
+1,638
| +8% | +$55.7K | 0.03% | 222 |
|
|
2019
Q3 | $476K | Buy |
19,856
+2,161
| +12% | +$51.8K | 0.02% | 265 |
|
|
2019
Q2 | $583K | Buy |
17,695
+5,985
| +51% | +$197K | 0.02% | 239 |
|
|
2019
Q1 | $433K | Sell |
11,710
-377
| -3% | -$13.9K | 0.02% | 243 |
|
|
2018
Q4 | $520K | Buy |
12,087
+1,541
| +15% | +$66.3K | 0.02% | 225 |
|
|
2018
Q3 | $498K | Buy |
+10,546
| New | +$498K | 0.02% | 222 |
|
|
2018
Q2 | – | Sell |
-8,161
| Closed | -$395K | – | 592 |
|
|
2018
Q1 | $395K | Buy |
8,161
+1,316
| +19% | +$63.7K | 0.02% | 218 |
|
|
2017
Q4 | $264K | Buy |
+6,845
| New | +$264K | 0.02% | 208 |
|